SPHK2 and early-onset autosomal dominant Alzheimer disease: Our own research observed a marked accumulation of d18:2 SLs (unpublished), following the ablation of sphingosine kinase 2 (SphK2) in a mouse model for Alzheimer’s disease (J20), which led to severe defects in myelin integrity78.